Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has shared an announcement.
Neuroscientific Biopharmaceuticals Ltd announced the cessation of 750,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of June 17, 2025. This cessation of securities may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth opportunities.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd is a company operating in the biopharmaceutical industry, focusing on the development of neurological treatments. The company is involved in creating innovative therapies aimed at addressing various neurological disorders.
Average Trading Volume: 380,474
Technical Sentiment Signal: Buy
Current Market Cap: A$8.82M
For an in-depth examination of NSB stock, go to TipRanks’ Overview page.